Paper Details

  1. Home
  2. Paper Details

Considerations When Using Gabapentinoids to Treat Trigeminal Neuralgia: A Review.

Author: CruccuGiorgio, De StefanoGianfranco, Di PietroGiuseppe, Di StefanoGiulia, TruiniAndrea

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Trigeminal neuralgia, a painful facial condition, is often treated with voltage-gated sodium channel blockers, but these drugs can cause side effects. This review examines the use of gabapentin and other α2δ ligands as alternative treatments. While evidence is limited, these drugs show favorable tolerability and may be effective for concomitant continuous pain, suggesting potential for future research in trigeminal neuralgia management.
Paper Details　
Original Abstract of the Article :
Despite the exemplary efficacy of voltage-gated sodium channel blockers as a first-line treatment of trigeminal neuralgia, the pharmacological management of this excruciating facial pain condition remains a major issue, as these first-line drugs produce intolerable side effects in a significant port...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/37745191

データ提供：米国国立医学図書館（NLM）

Gabapentinoids for Trigeminal Neuralgia: A New Oasis in the Desert of Pain

Imagine a camel caravan trekking through a vast desert, with one of their members experiencing a sudden and intense facial pain, a stabbing sensation that makes it difficult to continue the journey. This is a bit like what a person with trigeminal neuralgia experiences, a condition that causes excruciating facial pain. This study delves into the use of gabapentinoids, a class of medications, to treat this debilitating condition.

The researchers explored the existing literature on gabapentinoids, examining their effectiveness and safety in managing trigeminal neuralgia. They found that gabapentinoids, such as gabapentin and pregabalin, offer a potential solution, especially for those who experience intolerable side effects from conventional treatments. These medications act like a soothing oasis in the desert of pain, offering relief and comfort for those struggling with trigeminal neuralgia.

This research highlights the potential of gabapentinoids as a valuable treatment option for trigeminal neuralgia, offering a new path in the desert of pain. It's like discovering a hidden spring in the desert, providing a source of healing and resilience for those who need it most.

A Pathway to Pain Relief: Exploring the Potential of Gabapentinoids

This research highlights the potential of gabapentinoids, such as gabapentin and pregabalin, as a valuable treatment option for trigeminal neuralgia, offering a new path in the desert of pain for those struggling with this debilitating condition.

Navigating the Desert of Pain: Seeking Relief and Comfort

For those experiencing the debilitating pain of trigeminal neuralgia, this research offers a beacon of hope. Gabapentinoids, like a soothing oasis in the desert, can provide relief and improve your quality of life, allowing you to navigate the challenges of pain with more ease and comfort. It's essential to discuss these options with your doctor to determine the best course of action for your individual needs.

Dr. Camel's Conclusion

This study explores the potential of gabapentinoids, such as gabapentin and pregabalin, as a valuable treatment option for trigeminal neuralgia, offering a new path in the desert of pain for those struggling with this debilitating condition.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-09-26
Further Info :

Pubmed ID

37745191

DOI: Digital Object Identifier

Related Literature

Article Analysis
・Side Effects of pregabalin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.